# Assessment of Radiolabeled rhAnnexin V-128 in Infective Endocarditis

> **NCT02459613** · PHASE1,PHASE2 · TERMINATED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 11 (actual)

## Conditions studied

- Endocarditis
- Thrombosis

## Interventions

- **DRUG:** 99mTc-Annexin V-128 SPECT

## Key facts

- **NCT ID:** NCT02459613
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02-05
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02459613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02459613, "Assessment of Radiolabeled rhAnnexin V-128 in Infective Endocarditis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02459613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*